COMPUS Communiqué – Vol. 3, No. 10

August 16, 2007

In This Issue

COMPUS Proton Pump Inhibitor Project

Intervention Tools Posted

The Canadian Agency for Drugs and Technologies in Health (CADTH), through its COMPUS program, would like to thank you for your feedback on the evidence-based intervention tools selected for the COMPUS Proton Pump Inhibitor (PPI) project. Stakeholder feedback was taken into consideration in the creation of the final versions of these tools, which are now publicly available on the CADTH web site.

Didactic Presentations for Pharmacists and Physicians
  • Designed for pharmacist or physician education meetings.
  • Continuing medical education providers may use these presentation slides, in part or in whole, for education on the optimal prescribing and use of PPIs.

Upskilling Document
  • Created to provide relevant reference material to qualified interventionists (i.e., continuing medical education providers, academic detailers).
  • One of the intended uses of this detailed document is as a backgrounder for those delivering the didactic presentations.

Evaluation Framework
  • Created to provide options for qualitative and quantitative evaluation that could be undertaken by educational providers, their sponsors, or COMPUS to evaluate the effectiveness of COMPUS intervention tools.
  • Includes a series of surveys for presenters and participants.

Final versions of the interactive presentations for physicians and pharmacists and the self-audit tool for physicians will be posted in the coming weeks. If you are interested in these draft documents for continuing medical education or other purposes in the meantime, please contact Sandra Rees.

Visit the CADTH web site to access all of our PPI Optimal Therapy Reports and Intervention Tools.

COMPUS Diabetes Management Project

Update

The COMPUS project on insulin analogues under the diabetes management topic area continues on target. The COMPUS Expert Review Committee (CERC) together with the COMPUS team is working toward recommendations based on clinical and economic evidence, expected in September.

Stakeholders will have an opportunity to provide input on the draft Scientific Report in early fall. CADTH would like to thank those who have provided feedback as part of the COMPUS process and encourage all interested parties to participate.

Future issues of the COMPUS Communiqué will announce feedback opportunities and results.

Employment Opportunities

CADTH has many exciting job openings. If you’re interested in joining our growing team of professionals, visit the Careers/Job Listings on the CADTH web site.